Your browser doesn't support javascript.
loading
A Chimera of Th1 Stimulatory Proteins of Leishmania donovani Offers Moderate Immunotherapeutic Efficacy with a Th1-Inclined Immune Response against Visceral Leishmaniasis.
Ratnapriya, Sneha; Yadav, Narendra Kumar; Dube, Anuradha; Sahasrabuddhe, Amogh Anant.
Affiliation
  • Ratnapriya S; Molecular and Structural Biology Division, CSIR-Central Drug Research Institute, Lucknow 226031, India.
  • Keerti; Molecular and Structural Biology Division, CSIR-Central Drug Research Institute, Lucknow 226031, India.
  • Yadav NK; Molecular and Structural Biology Division, CSIR-Central Drug Research Institute, Lucknow 226031, India.
  • Dube A; Molecular Parasitology and Immunology Division, CSIR-Central Drug Research Institute, Lucknow 226031, India.
  • Sahasrabuddhe AA; Molecular and Structural Biology Division, CSIR-Central Drug Research Institute, Lucknow 226031, India.
Biomed Res Int ; 2021: 8845826, 2021.
Article in En | MEDLINE | ID: mdl-34095312
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leishmania donovani / Th1 Cells / Leishmaniasis, Visceral Limits: Animals Language: En Journal: Biomed Res Int Year: 2021 Document type: Article Affiliation country: India Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leishmania donovani / Th1 Cells / Leishmaniasis, Visceral Limits: Animals Language: En Journal: Biomed Res Int Year: 2021 Document type: Article Affiliation country: India Country of publication: Estados Unidos